Hepatoprotective Effect of Metadoxine on Acetaminophen-induced Liver Toxicity in Mice

Document Type : Original Article

Authors

1 Department of Pharmacology and Toxicology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical Sciences Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Metadoxine (pyridoxine pyrrolidone carboxylate) is considered to be a beneficial agent for the treatment of experimental hepatotoxicity due to alcohol, CCl4, and bile duct ligation. Hence, the therapeutic effect of metadoxine and N-acetylcysteine (NAC) as reference drug was investigated in mice exposed to acute hepatotoxicity induced by a single oral toxic dose of acetaminophen (650 mg/kg). Materials and Methods: Metadoxine (200 and 400 mg/kg) and NAC (300 mg/kg) were given orally (p. o.), 2 h after acetaminophen administration. Serum aminotransferases, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), total bilirubin, hepatic glutathione (GSH), and malondialdehyde (MDA) levels were determined for evaluating the extent of hepatotoxicity due to acetaminophen and its protection by metadoxine. Results: Findings indicated that metadoxine significantly reduced the level of serum ALT, AST, and ALP but not total bilirubin which increased by acetaminophen intoxication. Administration of metadoxine also attenuated oxidative stress by suppressing lipid peroxidation (MDA) and prevented the depletion of reduced GSH level which caused by acetaminophen toxicity. Besides, metadoxine ameliorated histopathological hepatic tissue injury induced by acetaminophen. Conclusion: In most parameters examined, the effect of metadoxine was comparable to NAC. Hence, metadoxine could be considered as a beneficial therapeutic candidate to protect against acute acetaminophen hepatotoxicity.

Keywords

1.
Gu X, Manautou JE. Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med 2012;14:e4.  Back to cited text no. 1
[PUBMED]    
2.
Lee WM. Drug-induced acute liver failure. Clin Liver Dis 2013;17:575-86, viii.  Back to cited text no. 2
[PUBMED]    
3.
Natanzi E, Reza A, Mahmoudian S, Minaeie B, Sabzevari O. Hepatoprotective activity of phloretin and hydroxychalcones against acetaminophen induced hepatotoxicity in mice. Iran J Pharm Res 2011;7:89-97.  Back to cited text no. 3
    
4.
Hodgman MJ, Garrard AR. A review of acetaminophen poisoning. Crit Care Clin 2012;28:499-516.  Back to cited text no. 4
[PUBMED]    
5.
Lauterburg BH, Corcoran GB, Mitchell JR. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 1983;71:980-91.  Back to cited text no. 5
[PUBMED]    
6.
Vonghia L, Leggio L, Ferrulli A, Bertini M, Gasbarrini G, Addolorato G, et al. Acute alcohol intoxication. Eur J Intern Med 2008;19:561-7.  Back to cited text no. 6
    
7.
Calabrese V, Ragusa N, Rizza V. Effect of pyrrolidone carboxylate (PCA) and pyridoxine on liver metabolism during chronic ethanol intake in rats. Int J Tissue React 1995;17:15-20.  Back to cited text no. 7
[PUBMED]    
8.
Gutiérrez-Ruiz MC, Bucio L, Correa A, Souza V, Hernández E, Gómez-Quiroz LE, et al. Metadoxine prevents damage produced by ethanol and acetaldehyde in hepatocyte and hepatic stellate cells in culture. Pharmacol Res 2001;44:431-6.  Back to cited text no. 8
    
9.
Calabrese V, Calderone A, Ragusa N, Rizza V. Effects of metadoxine on cellular status of glutathione and of enzymatic defence system following acute ethanol intoxication in rats. Drugs Exp Clin Res 1996;22:17-24.  Back to cited text no. 9
[PUBMED]    
10.
Felicioli R, Saracchi I, Flagiello AM, Bartoli C. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats. Int J Clin Pharmacol Ther Toxicol 1980;18:277-80.  Back to cited text no. 10
[PUBMED]    
11.
Fehér J, Lengyel G. A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). J Int Med Res 2003;31:537-51.  Back to cited text no. 11
    
12.
Annoni G, Contu L, Tronci MA, Caputo A, Arosio B. Pyridoxol L,2-pyrrolidon-5 carboxylate prevents active fibroplasia in CCl4-treated rats. Pharmacol Res 1992;25:87-93.  Back to cited text no. 12
    
13.
Laouar A, Klibet F, Bourogaa E, Benamara A, Boumendjel A, Chefrour A, et al. Potential antioxidant properties and hepatoprotective effects of juniperus phoenicea berries against CCl4 induced hepatic damage in rats. Asian Pac J Trop Med 2017;10:263-9.  Back to cited text no. 13
[PUBMED]    
14.
Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205.  Back to cited text no. 14
[PUBMED]    
15.
Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-8.  Back to cited text no. 15
[PUBMED]    
16.
Heidari R, Niknahad H, Jamshidzadeh A, Azarpira N, Bazyari M, Najibi A. Carbonyl traps as potential protective agents against methimazole-induced liver injury. J Biochem Mol Toxicol 2015;29:173-81.  Back to cited text no. 16
[PUBMED]    
17.
Plaa GL, Charbonneau M. Detection and evaluation of chemically induced liver injury. In: Hayess AW, editor. Principles and Methods of Toxicolog. 5th ed. Massachussets: CRC Press; 2008. p. 1465-507.  Back to cited text no. 17
    
18.
Muthulingam M. Antihepatotoxic effects of boerhaavia diffusa L. on antituberculosis drug, rifampicin induced liver injury in rats. J Pharmacol Toxicol 2008;3:75-83.  Back to cited text no. 18
    
19.
Giannini EG, Testa R, Savarino V. Liver enzyme alteration: A guide for clinicians. CMAJ 2005;172:367-79.  Back to cited text no. 19
[PUBMED]    
20.
Woolbright BL, Jaeschke H. Mechanisms of acetaminophen-induced liver necrosis. In: Hinson JA, Roberts DW, James LP, editors. Adverse Drug Reactions. Kanzas: Springer; 2010. p. 369-405.  Back to cited text no. 20
    
21.
Addolorato G, Ancona C, Capristo E, Gasbarrini G. Metadoxine in the treatment of acute and chronic alcoholism: A review. Int J Immunopathol Pharmacol 2003;16:207-14.  Back to cited text no. 21
[PUBMED]    
22.
Kumar A, Bachhawat AK. Pyroglutamic acid: Throwing light on a lightly studied metabolite. Curr Sci 2012;102:288-97.  Back to cited text no. 22
    
23.
Muriel P, Deheza R. Fibrosis and glycogen stores depletion induced by prolonged biliary obstruction in the rat are ameliorated by metadoxine. Liver Int 2003;23:262-8.  Back to cited text no. 23
[PUBMED]    
24.
Hsu CC, Cheng CH, Hsu CL, Lee WJ, Huang SC, Huang YC, et al. Role of vitamin B6 status on antioxidant defenses, glutathione, and related enzyme activities in mice with homocysteine-induced oxidative stress. Food Nutr Res 2015;59:25702.  Back to cited text no. 24
    
25.
Fehér J, Váli L, Blázovics A, Lengyel G. The beneficial effect of metadoxine (pyridoxine-pyrrolidone-carboxylate) in the treatment of fatty liver diseases. Clin Exp Med 2009;3:65-79.  Back to cited text no. 25
    
26.
Ki SH, Choi JH, Kim CW, Kim SG. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity. Chem Biol Interact 2007;169:80-90.  Back to cited text no. 26
[PUBMED]    
27.
Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J 2012;5:9-19.  Back to cited text no. 27
[PUBMED]    
28.
Blazka ME, Elwell MR, Holladay SD, Wilson RE, Luster MI. Histopathology of acetaminophen-induced liver changes: Role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 1996;24:181-9.  Back to cited text no. 28
[PUBMED]